Sunshine Nuohe: The Shanghai Stock Exchange has decided to terminate the review of the company's issuance of shares and convertible corporate bonds for the purchase of assets and the raising of supporting funds, as well as related transactions.

Sunshine Nuohe Announcement: The company held a board meeting on January 27, 2026, and decided to terminate the issuance of shares and convertible corporate bonds to purchase assets and raise matching funds, as well as related-party transactions, and withdraw the application documents. Subsequently, the company and the independent financial advisor, Guolian Minsheng Securities Sponsorship Limited, respectively submitted withdrawal applications to the Shanghai Stock Exchange. The Shanghai Stock Exchange issued a decision on January 28, 2026, to terminate the review of Beijing Sunshine Nuohe Pharmaceutical Research Co., Ltd.'s issuance of shares and convertible corporate bonds to purchase assets and raise matching funds, as well as related-party transactions.